Be part of the knowledge.™

Public Health

2928

LikeLikedUnlike

Episodes 391-405 of 833

Smart Phones, Genomics and AI: Health Care's Next Frontier in Personalized Medicine
Conversations on Health Care
Smart Phones, Genomics and AI: Health Care's Next Frontier in Personalized Medicine
The Quality Payment Program in 2019: What to Know About Upgrading Your EHR
Perspectives with the AMA
The Quality Payment Program in 2019: What to Know About Upgrading Your EHR
- Shira Johnson, MD
  Peer
- Laura Hoffman
  Peer
- Matt Reid
  Peer
What Are Your Quality Reporting Options?
Perspectives with the AMA
What Are Your Quality Reporting Options?
- Matt Birnholz, MD
  Peer
- Koryn Rubin
  Peer
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
FDA Drug Information Updates
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
Is Telemedicine the New House Call?
Clinician's Roundtable
Is Telemedicine the New House Call?
- John Russell, MD
  Peer
- Judd Hollander, MD
  Peer
Skinny Liver: A Closer Examination of Fatty Liver Disease
NutritionEdge
Skinny Liver: A Closer Examination of Fatty Liver Disease
- Kathy King, RDN
  Peer
- Kristin Kirkpatrick, MS, RDN
  Peer
advertisement
Sustainable Beef Production: An Analysis of Cattle Industry Sustainability & Its Economic Impact
NutritionEdge
Sustainable Beef Production: An Analysis of Cattle Industry Sustainability & Its Economic Impact
- Kathy King, RDN
  Peer
Effects of Medicaid Access on Clinical Outcomes: Does Coverage Improve Health?
Clinician's Roundtable
Effects of Medicaid Access on Clinical Outcomes: Does Coverage Improve Health?
- Maurice Pickard, MD
  Peer
- Katherine Baicker
  Peer
Addressing the Challenges of Influenza Vaccination on US College Campuses
Everyday Family Medicine
Addressing the Challenges of Influenza Vaccination on US College Campuses
- Jennifer Caudle, DO
  Peer
- Lisa Ipp, MD
  Peer
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Project Oncology®
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
FDA Drug Information Updates
FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
FDA Drug Information Updates
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
advertisement
STI Screening & Counseling Strategies for Transgender Patients
Clinician's Roundtable
STI Screening & Counseling Strategies for Transgender Patients
- Matt Rosenberg, MD
  Peer
- Aiden Harrington, ANP, CNM
  Peer
Wealth-Associated Disparities in Death and Disability in the United States and England
The JAMA Report™
Wealth-Associated Disparities in Death and Disability in the United States and England
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
FDA Drug Information Updates
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard

Program Chapters

Segment Chapters

Playlist:

Recommended